Benzinga | Jul 16, 2020 07:11AM EDT

Canaccord Genuity Maintains Buy on T2 Biosystems, Raises Price Target to $4

Canaccord Genuity analyst Max Masucci maintains T2 Biosystems (NASDAQ:TTOO) with a Buy and raises the price target from $3 to $4.